Drug Shortage Report for TPN ELECTROLYTES
Report ID | 101570 |
Drug Identification Number | 00590215 |
Brand name | TPN ELECTROLYTES |
Common or Proper name | TPN ELECTROLYTES |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM ACETATE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE |
Strength(s) | 121MG 25.4MG 16.55MG 74.55MG 16.05MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 25 X 20mL PVL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-02-01 |
Actual start date | |
Estimated end date | |
Actual end date | 2020-01-31 |
Shortage status | Avoided shortage |
Updated date | 2020-01-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-12-18 | English | Compare |
v2 | 2019-12-18 | French | Compare |
v3 | 2020-01-31 | English | Compare |
v4 | 2020-01-31 | French | Compare |
Showing 1 to 4 of 4